HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Feng R Luo Selected Research

Colonic Neoplasms (Colon Cancer)

8/2005Prediction of active drug plasma concentrations achieved in cancer patients by pharmacodynamic biomarkers identified from the geo human colon carcinoma xenograft model.
7/2002Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Feng R Luo Research Topics

Disease

6Neoplasms (Cancer)
01/2017 - 08/2005
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2009 - 12/2006
2Colonic Neoplasms (Colon Cancer)
08/2005 - 07/2002
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2017
1Glioma (Gliomas)
07/2015
1Glioblastoma (Glioblastoma Multiforme)
07/2015
1Pleural Effusion (Pleural Effusions)
03/2010
1Prostatic Neoplasms (Prostate Cancer)
01/2007
1Carcinoma (Carcinomatosis)
08/2005
1Breast Neoplasms (Breast Cancer)
05/2004
1Colorectal Neoplasms (Colorectal Cancer)
07/2002

Drug/Important Bio-Agent (IBA)

4Phosphotransferases (Kinase)IBA
07/2015 - 10/2006
3Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2017 - 07/2015
3erdafitinibIBA
01/2017 - 07/2015
3Dasatinib (BMS 354825)FDA Link
03/2010 - 01/2007
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2006 - 08/2005
2ErbB Receptors (EGF Receptor)IBA
10/2006 - 08/2005
1Phosphates (Orthophosphate)IBA
01/2017
1Tyrosine Kinase InhibitorsIBA
06/2009
1Imatinib Mesylate (Gleevec)FDA Link
01/2007
1(4- ((1- (3- fluorophenyl)methyl)- 1H- indazol- 5- ylamino)- 5- methylpyrrolo(2,1- f)(1,2,4)triazin- 6- yl)carbamic acid 3-morpholinylmethyl esterIBA
10/2006
1Cetuximab (Erbitux)FDA Link
08/2005
1Immunoglobulin G (IgG)IBA
08/2005
1Monoclonal AntibodiesIBA
08/2005
1Biomarkers (Surrogate Marker)IBA
08/2005
1Proteins (Proteins, Gene)FDA Link
05/2004
1ElacridarIBA
05/2004
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
07/2002
1CamptothecinIBA
07/2002
1Fluorouracil (Carac)FDA LinkGeneric
07/2002
1Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2002
1Irinotecan (Camptosar)FDA LinkGeneric
07/2002

Therapy/Procedure

2Therapeutics
01/2017 - 07/2002
1Drug Therapy (Chemotherapy)
07/2002